Policy Briefings

Rottendorf Pharma Forms Strategic Alliance with Corealis Pharma to De-Risk OSD Scale-Up

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biopharmaceutical CDMO Facility

Axplora Inaugurates 4,000 sqm Production Block at Vizag API Site

Douglas Pharmaceuticals Appoints Sean Westbrook as Chief Executive Officer

Experic Appoints Matthew Mollan as Chief Executive Officer

Kincell Bio Partners with RegCell to Advance Treg Cell Therapy Toward Clinical Trials

Made Scientific Launches Exclusive Early Adopter Programme with Streamline Bio

AsymBio Establishes Integrated Biopharmaceutical CDMO Platforms Across Full Development Lifecycle

Fresenius Kabi Partners with Phlow to Onshore U.S. Epinephrine Injection Manufacturing

WuXi Biologics Earns EcoVadis Platinum Medal for Third Consecutive Year

Samsung Biologics Validates Product Carbon Footprint System With DNV

Scarab Genomics Signs Exclusive Clean Genome Licensing Deal With Bionova

Eurofins CDMO Alphora Secures NRC IRAP Support for Next-Generation ADC Project

OXB Expands Bristol Myers Squibb Partnership With Commercial Supply Agreement

Charles River Laboratories to Close Hanover, Md., Cell Therapy CDMO Site

Thermo Fisher Scientific to Close Franklin, Massachusetts Facility

BioDlink Goes Live With Veeva QMS to Advance GMP Digitalization

Samsung Biologics Partners With CEPI to Strengthen Pandemic Vaccine Manufacturing